Archive for September 2021
For five generations, Blount Fine Foods has found a recipe for growth
Blount Fine Foods, a fifth-generation family business in Fall River, has been growing at a 20% compound annual rate, with revenue quadrupling over the past decade. It’s the kind of growth one might expect from a tech startup, not a 140-year-old food company. Read More
Read MoreBoston Speaks Up with SmarterTravel CEO Jordan Staab
Jordan Staab is the CEO of SmarterTravel, an industry leader in online travel with a travel media portfolio including Airfarewatchdog, BookingBuddy, Family Vacation Critic, Oyster, SmarterTravel, and WhatToPack. Read More
Read MoreSecurity unicorn Snyk adds $75M in funding at $8.6B valuation
Boston-based Snyk Ltd., which builds security tools for developers, added $75 million from Atlassian Ventures and Salesforce Ventures to its latest late-stage round of financing. Read More
Read MoreAs vaccination deadlines loom, Mass. hospitals brace to lose hundreds of workers
While vaccination rates at Massachusetts hospitals are high, thousands of workers have yet to meet the criteria ahead of deadlines, which range from Oct. 1 at some hospitals to Nov. 1 at others. Read More
Read MoreVineyard Wind could have two offshore-wind ports in Massachusetts
The agreement depends on the success of Vineyard Wind’s bid in the state’s latest solicitation for proposals to generate wind energy off the Massachusetts coast. Read More
Read MoreMassachusetts cybersecurity firm raises $20.5M in Series B funding
The company moved from Newport to Fall River in early 2020 after Massachusetts offered it $200,000 in state tax credits. Read More
Read MoreCatalog raises $35M to commercialize its DNA data storage process
Catalog, a Boston-based startup working to enable DNA computing and data storage, has raised $35 million to help move towards commercializing its systems. Read More
Read MoreCambridge biotech Acceleron to be acquired by Merck for $11.5B
A major pharmaceutical company has agreed to pay $11.5 billion in cash for Cambridge-based Acceleron, which is developing drugs for blood disorders. Read More
Read MoreModerna plans to more than double HQ in Cambridge’s Kendall Square
The Cambridge biotech company is known around the globe for its successful development of a Covid-19 vaccine. Read More
Read MoreEven real estate investors report feeling more pessimistic about housing-market prospects
Small-scale real estate investors are feeling pessimistic about their prospects in the housing market as inventory constraints continue to plague buyers of all shapes and sizes. Read More
Read More